 |
|
|
| |
Improvements in Patient-Reported Outcomes in Older Adults Aged ≥50 Years With
HIV-1 After Switching to a 2-Drug Regimen of Fixed-Dose Combination DTG/3TC:
48-Week Results From the SALSA Study
|
| |
| |
AIDS 2022 July 29-Aug 1 Montreal
Princy N. Kumar,1 Laurent Hocqueloux,2 Celia Jonsson-Oldenbüttel,3 Miguel García Deltoro,4 Amanda E. Clarke,5 Simona Di Giambenedetto,6 Po-Liang Lu,7 Carlos Brites,8
James Oyee,9 Lee A. Evitt,10 Lori A. Gordon,11 Elizabeth Blair,11 Brian Wynne,11 Chinyere Okoli,10 Jean van Wyk,10 Julie Priest11
1Georgetown University Medical Center, Washington, DC, USA; 2Centre Hospitalier Regional d'Orleans, Orleans, France; 3MVZ München am Goetheplatz, Munich, Germany; 4Consortium General University Hospital of
Valencia, Valencia, Spain; 5Royal Sussex County Hospital and Brighton & Sussex Medical School, Brighton, UK; 6Fondazione Policlinico Universitario Agostino Gemelli IRCCS and Università Cattolica del Sacro Cuore,
Rome, Italy; 7Kaohsiung Medical University, Kaohsiung, Taiwan; 8Universidade Federal da Bahia, Salvador, Brazil; 9GSK, Brentford, UK; 10ViiV Healthcare, Brentford, UK; 11ViiV Healthcare, Durham, NC
|
| |
|
|
|
|
|
